Why did AREDS2 replace beta carotene with lutein and zeaxanthin?

✓ Accepted answer

AREDS2 replaced beta carotene with lutein and zeaxanthin primarily because the original formulation in the AREDS1 trial revealed a heightened risk of lung cancer in current smokers who took beta carotene. To create a safer, more universally applicable formula for eye health, researchers substituted this risky compound with these two macular pigments, which are naturally concentrated in dark leafy greens like kale and spinach.

• Safety Priority: The removal of beta carotene allows smokers to safely use the supplement without the documented increase in lung cancer risk observed in the earlier National Cancer Institute lung cancer trials.
• Enhanced Macular Density: Lutein and zeaxanthin accumulate in the macula, filtering harmful blue light and reducing oxidative stress, which helps protect the central part of the retina responsible for detailed vision.
• Proven Efficacy: The AREDS2 study demonstrated that the updated formula containing lutein and zeaxanthin was as effective as the original formula in slowing the progression of age-related macular degeneration in intermediate cases.
• Dietary Relevance: These carotenoids are found in high concentrations in foods like corn, orange peppers, and guacamole, supporting the link between diet quality and long-term retinal health.

admin · 2026-10-10 10:16:06